R1 RCM Inc. (NASDAQ:RCM) Given Consensus Rating of “Hold” by Analysts

Shares of R1 RCM Inc. (NASDAQ:RCM) have been given a consensus recommendation of “Hold” by the eighteen brokerages that are currently covering the firm, Marketbeat.com reports. Thirteen research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $15.79.

Several research analysts have recently commented on RCM shares. TD Cowen restated a “hold” rating and set a $14.30 price target (down from $20.00) on shares of R1 RCM in a research report on Monday, August 5th. Canaccord Genuity Group reiterated a “buy” rating and set a $15.00 price target on shares of R1 RCM in a research note on Monday, July 22nd. Morgan Stanley cut shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 8th. Cantor Fitzgerald downgraded shares of R1 RCM from a “strong-buy” rating to a “hold” rating in a research note on Friday, August 2nd. Finally, Jefferies Financial Group cut shares of R1 RCM from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st.

Institutional Investors Weigh In On R1 RCM

Institutional investors and hedge funds have recently bought and sold shares of the stock. Advisors Asset Management Inc. acquired a new stake in shares of R1 RCM in the first quarter valued at approximately $27,000. Van ECK Associates Corp boosted its stake in R1 RCM by 20.5% during the 4th quarter. Van ECK Associates Corp now owns 6,141 shares of the healthcare provider’s stock worth $65,000 after purchasing an additional 1,044 shares during the period. ANTIPODES PARTNERS Ltd purchased a new position in R1 RCM during the 2nd quarter worth $86,000. QRG Capital Management Inc. acquired a new position in R1 RCM in the first quarter valued at $132,000. Finally, Caas Capital Management LP purchased a new stake in shares of R1 RCM in the fourth quarter valued at about $148,000. 61.10% of the stock is owned by hedge funds and other institutional investors.

R1 RCM Stock Up 0.1 %

Shares of RCM opened at $13.99 on Tuesday. The company’s 50-day moving average price is $12.89 and its 200 day moving average price is $12.58. R1 RCM has a 12-month low of $8.87 and a 12-month high of $18.22. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 0.78. The firm has a market cap of $5.89 billion, a P/E ratio of -174.88 and a beta of 0.85.

R1 RCM (NASDAQ:RCM) last released its quarterly earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.03. The business had revenue of $627.90 million for the quarter, compared to the consensus estimate of $633.10 million. R1 RCM had a negative net margin of 1.39% and a negative return on equity of 1.16%. R1 RCM’s revenue for the quarter was up 12.0% compared to the same quarter last year. On average, sell-side analysts forecast that R1 RCM will post -0.2 earnings per share for the current year.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.